Effects of cyclosporin A on cultured human epidermal keratinocytes. Growth and 5-bromo-2'-deoxyuridine incorporation.
We have studied the in vitro effect of CsA at various doses (0.5, 1, 5, 10 micrograms/ml) on the growth and 5-bromo-2'-deoxyuridine (BrdU) incorporation by cultured normal human epidermal keratinocytes (EK). CsA was found to reduce the growth of EK at all doses used after 24, 48 and 72 h in culture, but the difference with appropriate controls became statistically significant for the dose of 10 micrograms/ml after a 48- and 72-h culture. On the other hand, CsA-treated EK comprised a reduced fraction of BrdU + (S-phase) cells, the difference being statistically significant for the dose of 10 micrograms/ml at 24, 48 and 72 h. Ultrastructural examination of CsA-treated EK, despite the presence of cytoplasmic vacuoles also observed in control EK did not show signs of severe cytoplasmic or nuclear damage. These results confirm the antiproliferative effect of CsA on cultured EK and suggest that at the concentration used, CsA acts through a cytostatic rather than a cytotoxic mechanism, most likely by blocking EK in an early phase (G0/G1) of the cell cycle.
Ramirez-Bosca
A
A
INSERM U209, CNRS URA 189, Dept. of Dermatology, Edouard Herriot Hospital, Lyon, France.
Kanitakis
J
J
Haftek
M
M
Faure
M
M
Castells-Rodellas
A
A
Thivolet
J
J
D002452:Cell Count; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003524:Cyclosporins / Q000494:pharmacology*; D006801:Humans; D015603:Keratinocytes / Q000166:cytology / Q000187:drug effects* / Q000648:ultrastructure; D008854:Microscopy, Electron / Q000379:methods; D013997:Time Factors
D003524:Cyclosporins